COMMUNIQUÉS West-GlobeNewswire

Supernus Announces Third Quarter 2018 Financial Results and Record Quarterly Revenue
06/11/2018
Total revenue of $103.0 million, a 28% increase over 2017 Net product sales of $100.2 million, a 28% increase over 2017 Operating earnings of $37.5 million, a 68% increase over 2017 Diluted earnings per share (GAAP) of [...]
Inspire Medical Systems, Inc. Announces Third Quarter 2018 Financial Results and Updates 2018 Outlook
06/11/2018
MINNEAPOLIS, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Capital Senior Living Corporation Reports Third Quarter 2018 Results
06/11/2018
DALLAS, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE:CSU), one of the nation’s largest operators of senior housing communities, today announced operating and financial [...]
MRI Interventions Announces FDA Clearance of ClearPoint® 2.0 Next-Generation Software Platform
06/11/2018
Initial Limited Market Release Shipments to Commence Immediately IRVINE, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced FDA clearance for the company’s latest software [...]
EyePoint Pharmaceuticals to Present at the Stifel 2018 Healthcare Conference
06/11/2018
WATERTOWN, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
CymaBay Reports Third Quarter 2018 Financial Results and Provides Corporate Update
06/11/2018
Conference call and webcast today at 4:30p.m. ET NEWARK, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY) a clinical-stage biopharmaceutical company focused on developing therapies for [...]
Fulgent Genetics Reports Third Quarter 2018 Financial Results
06/11/2018
Third Quarter 2018 Results : Revenue totals $5.6 million, growing 25% year over year and 4% sequentially Billable tests delivered total 5,569, growing 37% year over year GAAP gross margin improves 70 basis points [...]
Prothena Reports Third Quarter 2018 Financial Results and Provides R&D Update
06/11/2018
Net cash used in operating and investing activities was $33.7 million in the third quarter and $7.5 million in the first nine months of 2018; quarter-end cash and restricted cash position of $455.6 million provides [...]
Rubius Therapeutics to Participate in Jefferies London Healthcare Conference
06/11/2018
CAMBRIDGE, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company developing an entirely new class of allogeneic cellular therapies, announced today that Pablo J. [...]
iCAD to Report Third Quarter and Nine Months Ended September 30, 2018 Financial Results on Tuesday, November 13th
06/11/2018
NASHUA, N.H., Nov. 06, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial [...]
Eidos Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
06/11/2018
SAN FRANCISCO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), a clinical stage biopharmaceutical company focused on addressing the large unmet need in transthyretin (TTR) amyloidosis ( [...]
SeaSpine Reports Third Quarter 2018 Financial Results
06/11/2018
CARLSBAD, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
GBT Reports Recent Business Progress and Provides Third Quarter 2018 Financial Results
06/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today reported business progress and financial results for the third quarter ended September 30, 2018. “ [...]
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2018
06/11/2018
RANCHO CUCAMONGA, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its Third quarter of 2018 ended September 30, 2018, after [...]
CytomX Therapeutics Announces Third Quarter 2018 Financial Results
06/11/2018
ESMO Presentations Support CX-072 Product Profile and Probody™ Proof-of-Concept Advancement of Clinical Stage Probody Drug Conjugate Programs, CX-2009 and CX-2029 CX-188 IND Filing Marks Fifth Probody Therapeutic to [...]
Dova Pharmaceuticals to Present at Upcoming Investor Conferences
06/11/2018
DURHAM, N.C., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced that the management team will present a company overview at four upcoming investor conferences: On Tuesday, [...]
Athersys Reports Third Quarter 2018 Results
06/11/2018
Management to host conference call at 4:30pm EST today CLEVELAND, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the period ended September 30, 2018. Highlights [...]
Aravive Reports Third Quarter 2018 Financial Results and Provides Company Updates
06/11/2018
- Merger completed; now operating as Aravive, Inc. (Nasdaq:ARAV), a clinical-stage biopharmaceutical company advancing innovative oncology therapeutics - FDA Fast Track designation granted for lead candidate, AVB-S6-500 [...]
Myriad Genetics Reports Fiscal First-Quarter 2019 Financial Results
06/11/2018
Total First-Quarter Revenues of $202.3 Million, Up 13 Percent First-Quarter Diluted EPS of ($0.01) and Adjusted EPS of $0.43, Up 48 Percent Revised Full-Year Revenue Guidance to $855 to $865 Million; Maintained Diluted [...]

Pages